Omicron SARS-CoV-2 variant: An observational study from a hospital in Southern India
References
- COVID-19 Weekly Epidemiological Update (as of 16th January 2022). Edition 75 dated 3rd January 2022. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update
- COVID-19 Dashboard. Ministry of Health and Family Welfare, Government of India. 21st January 2022. Available from: https://www.mohfw.nic.in
- World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern 2021. Available from: https://www.who.int/news/item/26-11-2021-classification-ofomicron-(b.1.1.529)-sars-cov-2-variant-of-concern
- Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States World Health Organization HQ: Headquarters, Geneva, Switzerland. Update #5: 7 January 2022. Available from: https://www.who.int/publications/m/item/enhancing-readinessfor-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states
- SARS-CoV-2 (COVID-19 Virus) Variant of Concern (VoC) Screening and Genomic Sequencing for Surveillance. Public Health Ontario. Ontario Agency for Health Protection and Promotion. Updated on 20 December 2021. Available from: https://www.publichealthontario.ca/en/laboratory-services/test-information-index/covid-19-voc
- Bhatnagar T, Chaudhuri S, Ponnaiah M, Yadav PD, Sabarinathan R, Sahay RR et al. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and Delta variant in India, 2021: A case-control study. Preprint in English. Europe PMC ID: ppcovidwho-294258
- Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK et al. Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1.
- Espenhain L, Funk T, Overvad M, Edslev SM, Fonager J, Ingham AC. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Euro Surveill. 2021;26(50). 2101146. doi:10.2807/1560-7917.ES.2021.26.50.2101146
- S. Kannan, P. Shaik Syed Ali, A. Sheeza. Omicron (B.1.1.529) – variant of concern – molecular profile and epidemiology: a mini review. European Review for Medical and Pharmacological Sciences. 2021; 25: 8019-8022. doi: 10.26355/eurrev_202112_27653
- WHO COVID-19 Dashboard. Available from: https://covid19.who.int/
- MoHFW/COVID-19 States data/25th January2022/3. Release ID: 1792334. Available from: https://www.pib.gov.in/PressReleseDetail.aspx?PRID=1792330
- Clinical guidance for management of adult Covid-19 patients. AIIMS/ ICMR-COVID-19 National Task Force/ Joint Monitoring Group. Ministry of Health & Family Welfare, Government of India. 14th January 2022. Available from URL: https://www.mohfw.gov.in/pdf/ClinicalGuidanceforManagementofAdultCovid19Patientsupdatedason17thJanuary2022.pdf
- Selvavinayagam TS, Somasundaram A, Nirmalson J, Kumar CAB, Aravintharaj S. S Gene target failure profiling – Declining third wave COVID-19. DPH Newsletter. 2022;2(3):1-4. Available from: https://www.tndphpm.com/wp-content/uploads/documents/Vol-2-Issue-3-February-01-2022-1.pdf
- Kim MK, Lee B, Choi YY, Um J, Lee KS, Sung HK, Kim Y et al. Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea. J Korean Med Sci. 2022; 37(3):e31. doi: 10.3346/jkms.2022.37.e31.
- Kumar RM, Vivian TJW, Selvavinayagam TS, Somasundaram A, Parthipan K, Raju S et al. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022. Indian Journal of Medical Research 2022;155(1):1-6. doi: 10.4103/ijmr.ijmr_312_22
- Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. European Review for Medical and Pharmacological Sciences. 2021;25(24):8012-18. doi.org/10.26355/eurrev_202112_27652
- National Institute for Communicable Diseases. South African COVID-19 Weekly Epidemiology Brief: week 52 2021. National Institute for Communicable Diseases (NICD) South Africa; 2022. Available from: https://www.nicd.ac.za/wp-content/uploads/2022/01/COVID-19-Weekly-Epi-Brief_Week52.pd
- Sharma RP, Gautam S, Sharma P, Singh R, Sharma H, Parsoya D et al. Clinico epidemiological profile of Omicron variant of SARS CoV2 in Rajasthan. medRxiv 2022.02.11.22270698; doi: https://doi.org/10.1101/2022.02.11.22270698
- Ewen Callaway. The race for coronavirus vaccines: a graphical guide. Nature 2000;580(7805):576.
- WHO target product profiles for COVID-19 vaccines. April 9, 2020. Available from: https:// www.who.int/publications/m/item/who target-product-profiles-for-covid-19-vaccines.
- Bartsch SM, O’Shea KJ, Ferguson MC, et al. Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention. Am J Prev Med 2020;59: 493–503.
- Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States World Health Organization HQ: Headquarters, Geneva, Switzerland. Update #5: 7 January 2022. Available from: https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states
- Dejnirattisai W, Huo J,Zhou D, Zahradník J, Supasa P, Liu C. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Epub ahead of print bioRxiv 2021.12.03.471045; doi: https://doi.org/10.1101/2021.12.03.471045
- Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.The Lancet 2022:399 (10335):1618-24. doi: https://doi.org/10.1016/S0140-6736(22)00327-0
- Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6.
DOI: https://doi.org/10.2478/acm-2022-0010 | Journal eISSN: 1338-4139 (formerly 1335-8421) | Journal ISSN: 1335-8421
Language: English
Page range: 79 - 90
Submitted on: May 9, 2022
Accepted on: Jul 1, 2022
Published on: Aug 23, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2022 Jayanthi Rangarajan, Rajesh Jayanandan, Raviganesh Pravin Kumar, Arun Murugan, Pavithra Gnanavel, N Devasena, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.